The Asia-Pacific Elastography Imaging Market was valued at USD 552.80 million in 2024, and is projected to reach USD 873.06 million by 2030, rising at a CAGR of 7.92%. The rising prevalence of chronic diseases is increasing the demand for non-invasive diagnostic techniques, while technological advancements in ultrasound and MRI elastography are enhancing imaging accuracy and accessibility. The expansion of healthcare infrastructure and diagnostic centers, particularly in countries such as China and India, is further fueling market growth. In addition, the growing geriatric population is contributing to a higher incidence of chronic diseases, necessitating advanced diagnostic solutions. Medical tourism in countries such as India and Thailand, coupled with government initiatives promoting early disease detection and preventive healthcare, is boosting adoption.
The increasing prevalence of chronic disorders such as liver disease, cancer, musculoskeletal conditions, and cardiovascular diseases is driving the demand for advanced imaging technologies in the Asia Pacific region. Elastography is highly efficient in assessing tissue stiffness, detecting fibrosis, and distinguishing between benign and malignant lesions, making it a preferred non-invasive alternative to traditional biopsy methods. Its ability to provide real-time, accurate, and early disease detection enhances clinical decision-making, particularly in the diagnosis of liver fibrosis, breast cancer, and thyroid disorders. As healthcare providers prioritize early diagnosis and precision medicine, the adoption of elastography is growing across hospitals, diagnostic centers, and research institutes in the Asia Pacific region.
The growing medical tourism industry in the Asia Pacific region is expected to be a significant driver of elastography imaging market growth. In September 2024, China’s Ministry of Commerce, National Health Commission, and National Medical Products Administration issued a joint circular allowing foreign investors to operate hospitals in major cities such as Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen, and Hainan province. According to the South China Morning Post, China also plans to permit fully foreign-owned hospitals and allow foreign investment.
However, India already has a well-established medical tourism industry, attracting patients with affordable yet high-quality healthcare services, China is in the early stages of developing its medical tourism sector but is expected to witness a rapid boom. India has positioned itself as a global leader in medical tourism, whereas China is actively expanding its healthcare capabilities. This rising influx of international patients seeking cost-effective, high-quality diagnostic and treatment options is expected to fuel demand for advanced imaging technologies, including elastography, as hospitals and diagnostic centers aim to enhance their service offerings.
This product will be delivered within 1-3 business days.
The increasing prevalence of chronic disorders such as liver disease, cancer, musculoskeletal conditions, and cardiovascular diseases is driving the demand for advanced imaging technologies in the Asia Pacific region. Elastography is highly efficient in assessing tissue stiffness, detecting fibrosis, and distinguishing between benign and malignant lesions, making it a preferred non-invasive alternative to traditional biopsy methods. Its ability to provide real-time, accurate, and early disease detection enhances clinical decision-making, particularly in the diagnosis of liver fibrosis, breast cancer, and thyroid disorders. As healthcare providers prioritize early diagnosis and precision medicine, the adoption of elastography is growing across hospitals, diagnostic centers, and research institutes in the Asia Pacific region.
The growing medical tourism industry in the Asia Pacific region is expected to be a significant driver of elastography imaging market growth. In September 2024, China’s Ministry of Commerce, National Health Commission, and National Medical Products Administration issued a joint circular allowing foreign investors to operate hospitals in major cities such as Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen, and Hainan province. According to the South China Morning Post, China also plans to permit fully foreign-owned hospitals and allow foreign investment.
However, India already has a well-established medical tourism industry, attracting patients with affordable yet high-quality healthcare services, China is in the early stages of developing its medical tourism sector but is expected to witness a rapid boom. India has positioned itself as a global leader in medical tourism, whereas China is actively expanding its healthcare capabilities. This rising influx of international patients seeking cost-effective, high-quality diagnostic and treatment options is expected to fuel demand for advanced imaging technologies, including elastography, as hospitals and diagnostic centers aim to enhance their service offerings.
Asia Pacific Elastography Imaging Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For the purpose of this study, the analyst has segmented the Asia Pacific elastography market report on the basis of modality, application, end use, and country:Modality Outlook (Revenue, USD Million, 2018-2030)
- Ultrasound
- Magnetic Resonance Imaging
Application Outlook (Revenue, USD Million, 2018-2030)
- General Imaging
- Hepatology
- Breast
- Cardiology
- Nephrology
- Orthopedic and Musculoskeletal
End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Imaging Centers
- Other End Use
Country Outlook (Revenue, USD Million, 2018-2030)
- China
- Japan
- India
- Thailand
- South Korea
- Australia
This report addresses:
- Market intelligence to enable effective decision-making.
- Market estimates and forecasts from 2018 to 2030.
- Growth opportunities and trend analyses.
- Segment and regional revenue forecasts for market assessment.
- Competition strategy and market share analysis.
- Product innovation listings for you to stay ahead of the curve.
- COVID-19's impact and how to sustain in this fast-evolving market.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Asia Pacific Elastography Imaging Market Variables, Trends & Scope
Chapter 4. Asia Pacific Elastography Imaging Market: Modality Estimates & Trend Analysis
Chapter 5. Asia Pacific Elastography Imaging Market: Application Estimates & Trend Analysis
Chapter 6. Asia Pacific Elastography Imaging Market: End Use Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Chapter 8. Asia Pacific Elastography Imaging Market: Country Estimates & Trend Analysis By Modality, Application, End Use
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this Asia-Pacific Elastography Imaging market report include:- Canon Medical Systems Corporation
- Esaote SpA
- FUJIFILM Corporation
- GE Healthcare
- Hitachi, Ltd
- Koninklijke Philips N.V.
- Mindray Bio-Medical Electronics Co., Ltd.
- Samsung Medison Co., Ltd.
- Siemens
- Toshiba America Medical Systems, Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 90 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 552.8 Million |
| Forecasted Market Value ( USD | $ 873.06 Million |
| Compound Annual Growth Rate | 7.9% |
| Regions Covered | Asia Pacific |
| No. of Companies Mentioned | 11 |
